Submitted by Anonymous (not verified) on 4 February 2026 - 16:00
Human medicines European public assessment report (EPAR): Kirsty (previously Kixelle), insulin aspart, Date of authorisation: 05/02/2021, Revision: 5, Status: Authorised
Source:
